Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP510163.RAa3NIBZQB5PS6QeD3a4n-8YqC1Tj-V8_hKtgAxO0xDpk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP510163.RAa3NIBZQB5PS6QeD3a4n-8YqC1Tj-V8_hKtgAxO0xDpk130_assertion type Assertion NP510163.RAa3NIBZQB5PS6QeD3a4n-8YqC1Tj-V8_hKtgAxO0xDpk130_head.
- NP510163.RAa3NIBZQB5PS6QeD3a4n-8YqC1Tj-V8_hKtgAxO0xDpk130_assertion description "[Patients with renal involvement had increased surface expression of CXCR3 and CCR3 (P = 0.04 in both) and a lower level of soluble IP-10 compared with patients without renal disease (P = 0.025) and compared with controls (P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP510163.RAa3NIBZQB5PS6QeD3a4n-8YqC1Tj-V8_hKtgAxO0xDpk130_provenance.
- NP510163.RAa3NIBZQB5PS6QeD3a4n-8YqC1Tj-V8_hKtgAxO0xDpk130_assertion evidence source_evidence_literature NP510163.RAa3NIBZQB5PS6QeD3a4n-8YqC1Tj-V8_hKtgAxO0xDpk130_provenance.
- NP510163.RAa3NIBZQB5PS6QeD3a4n-8YqC1Tj-V8_hKtgAxO0xDpk130_assertion SIO_000772 14596426 NP510163.RAa3NIBZQB5PS6QeD3a4n-8YqC1Tj-V8_hKtgAxO0xDpk130_provenance.
- NP510163.RAa3NIBZQB5PS6QeD3a4n-8YqC1Tj-V8_hKtgAxO0xDpk130_assertion wasDerivedFrom befree-20150227 NP510163.RAa3NIBZQB5PS6QeD3a4n-8YqC1Tj-V8_hKtgAxO0xDpk130_provenance.
- NP510163.RAa3NIBZQB5PS6QeD3a4n-8YqC1Tj-V8_hKtgAxO0xDpk130_assertion wasGeneratedBy ECO_0000203 NP510163.RAa3NIBZQB5PS6QeD3a4n-8YqC1Tj-V8_hKtgAxO0xDpk130_provenance.